Drug Profile
Aponeurin
Alternative Names: AponeurinLatest Information Update: 25 Jan 2011
Price :
$50
*
At a glance
- Originator Neuraxo Biopharmaceuticals
- Class
- Mechanism of Action Collagen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 25 Jan 2011 No development reported - Preclinical for Stroke in Germany (unspecified route)
- 29 Jul 2005 Aponeurin is available for licensing or partnering(http://www.neuraxo.com)
- 18 Apr 2005 Preclinical trials in Stroke in Germany (unspecified route)